ABEO vs CSGP · rev $3.5M vs P/E 484, rev $2.74B
Abeona Therapeutics Inc (ABEO) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
ABEO currently screens at market cap $301.8M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the ABEO and CSGP stock pages for the full models.
Not investment advice.